drugset / Trial / NCT00191009
Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will compare atomoxetine to placebo when taken with current standard Alzheimer's Disease medications. The treatment will take approximately 6 months and it is hypothesized atomoxetine will significantly improve cognitive performance as compared to placebo.
Timeline
- Start
- 2003-10
- Primary completion
- —
- Completion
- 2006-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | — | — |